Funding search · Alzheimer'S Disease Research Foundation · grants

Alzheimer'S Disease Research Foundation: all 448 grants

Largest first · $100.1M across 2022–2025 · back to the overview

$120,015
Washington University · Saint Louis, MO · 2022
Characterization of molecular biomarker profiles throughout the pathobiological continuum
$118,450
Beth Israel Deaconess Medical Center · Boston, MA · 2023
Agp: genomic variant calling and data management for the cure alzheimer's fund alzheimer's genome project
$115,000
Icahn School of Medicine at Mount Sinai · New York, NY · 2025
Cross-species analysis of microglial states in heterogeneous alzheimer's disease progression
$115,000
New York University · New York, NY · 2022
Nic: investigation of ad risk alleles in astrocytes focus on cholesterol transport and microglia interactions
$115,000
Salk · La Jolla, CA · 2022
Circuits: impact of epigenetic and cellular variants on alzheimers disease pathology
$113,655
Washington University · St Louis, MO · 2023
Characterization of molecular biomarker profiles throughout the pathobiological continuum
$103,168
University of Michigan · Ann Arbor, MI · 2025
Non-invasive delivery of il-2 to the cns for local expansion of tregs and prevention of neurodegeneration in tauopathy
$100,625
Massachusetts General Hospital · Boston, MA · 2025
An engineered platform to model the yolk sac-brain interactions in alzheimer's disease
$100,625
Massachusetts General Hospital · Boston, MA · 2025
Characterization and optimization of cns-penetrant hdac11-selective inhibitors in alzheimer's disease models
$100,625
Trustees of Tufts College Dba Tufts University · Medford, MA · 2025
Elucidating the interplay between ad genetic variants using human ipsc-derived microglia-like cells
$100,625
University of Pittsburgh · Pittsburgh, PA · 2025
An engineered platform to model the yolk sac-brain interactions in alzheimer's disease
$100,600
Massachusetts General Hospital · Boston, MA · 2025
Elucidating the interplay between ad genetic variants using human ipsc-derived microglia-like cells
$100,000
Albert Einstein College of Medicine · Bronx, NY · 2022
Application of machine learning methods in alzheimers disease clinical trials
$98,083
Washington University in St Louis · St Louis, MO · 2025
Non-invasive delivery of il-2 to the cns for local expansion of tregs and prevention of neurodegeneration in tauopathy
$95,594
Massachusetts General Hospital · Boston, MA · 2023
General scientific support
$92,000
St Jude Children'S Research Hospital · Memphis, TN · 2025
Decipher the astrocyte cell-surface proteome in alzheimer's disease
$92,000
St Jude Children'S Research Hospital · Memphis, TN · 2024
Decipher the astrocyte cell-surface proteome in alzheimer's disease
$86,250
New York Genome Center · New York, NY · 2025
Cross-species analysis of microglial states in heterogeneous alzheimer's disease progression
$86,250
Boston Children'S Hospital · Boston, MA · 2024
Bee: neuroinflammation at the choroid plexus in alzheimer's disease - supplement to yr 1 (of2)
$82,166
Stony Brook · Stony Brook, NY · 2022
Bee: cns fluid homeostasis and waste clearance in alzheimers disease characterized by mri
$80,500
Boston Children'S Hospital · Boston, MA · 2025
How body-brain inflammatory signals via border macrophages alter the neuroimmune landscape and drive alzheimer's pathology
$80,500
Icahn School of Medicine at Mount Sinai · New York, NY · 2025
Combinatorial roles of eed and picalm in microglial clearance pathways in alzheimer's disease
$80,500
National Institute of Neurological Disorders & Stroke · Bethesda, MD · 2025
Dynamic investigation of lymphatic pathway interconnections for cerebrospinal fluid clearance of the human central nervous system in vivo under physiological conditions of the brain's borders
$80,500
New York University School of Medicine · New York, NY · 2025
Astrocyte network structure and function in alzheimer's disease
$80,500
President and Fellows of Harvard College · Cambridge, MA · 2025
Fbat-equivalence testing in the presence of model uncertainty for the cure alzheimers genome project
$80,500
Regents of the University of California San Diego · La Jolla, CA · 2025
Mechanisms regulating neurovascular function in alzheimer's disease
$80,500
The Regents of the University of California San Francisco · San Francisco, CA · 2025
Define adgrg1-mediated protective microglial response to tau tangles in alzheimer's disease
$80,500
Washington University in St Louis · St Louis, MO · 2025
Sleep augmentation reinforces neural computation, enhances cognition, and mitigates neurodegenerative disease symptoms
$80,500
Weill Medical College of Cornell University · New York, NY · 2025
Microglial-astrocytic mechanisms of apoe3 christchurch-mediated resilience to tauopathy
$78,090
University of Kentucky · Lexington, KY · 2025
Assessing the role of apoe in glial lipid droplet metabolism and function
$77,709
Washington University in St Louis · St Louis, MO · 2025
Suppressing neuroinflammation with a targeted protein degradation strategy in a tauopathy mouse model
$57,500
Boston Children'S Hospital · Boston, MA · 2025
Tracking inflammation and repair at the choroid plexus in alzheimer's disease
$57,500
Houston Methodist Research Institute (Houston Methodist Hospital Foundation · Houston, TX · 2025
Cancer-derived extracellular vesicle micrornas as systemic modulators of alzheimer's disease
$57,500
Maryland Medical Legal Foundation · Baltimore, MD · 2025
Bridge funding for a younger diverse human brain bank to investigate early ad pathology
$57,500
Northwestern University · Chicago, IL · 2025
Role of annexin a6-mediated membrane repair in alzheimer's pathology
$57,500
University of Southern California · Los Angeles, CA · 2025
Neural stem cell rejuvenation for symptomatic alzheimer's disease
$57,500
University of Michigan · Ann Arbor, MI · 2023
In vivo models for golgi fragmentation and the molecular pathogenesis of alzheimer's disease
$52,477
Washington University in St Louis · St Louis, MO · 2024
Non-invasive delivery of il-2 to the cns for local expansion of tregs and prevention of neurodegeneration in tauopatthy
$50,312
University of Virginia · Charlottesville, VA · 2025
The role of planar cell polarity proteins in tau oligomer-induced synapse degeneration
$40,250
Harvard Medical School · Boston, MA · 2023
Genetic ancestry-specific risk estimation of alzheimer's disease (ad) in the apoe region
$38,944
President and Fellows of Harvard College · Cambridge, MA · 2025
Precision medicine prediction model for alzheimer's disease using cooperative learning approaches for multi-omic data (supplement)
$24,957
Duke University School of Medicine · Durham, NC · 2024
Utility of blood based markers for predicting aria and its course in mci and ad subjects undergoing routine clinical treatment with amyloid-directed antibodies
$24,589
University of Miami · Atlanta, GA · 2025
2-deoxyglucose and its analogs as novel therapeutics to build resilience to alzheimer's disease
$24,589
University of Miami · Atlanta, GA · 2024
2-deoxyglucose and its analogs as novel therapeutics to build resilience to alzheimer's disease
$9,752
Massachusetts Institute of Technology · Cambridge, MA · 2025
Dissecting microglial state dynamics in alzheimer's disease (supplement)
$8,533
Massachusetts General Hospital · Boston, MA · 2025
Alzheimer's disease tau consortium: toxic consequences of early tau seeding (supplement)
$4,721
Medical College of Wisconsin · Milwaukee, WI · 2024
Relationship between alzheimer's disease risk and outcomes of mild repetitive neurotrauma
$4,025
Massachusetts General Hospital · Boston, MA · 2025
Role of cd8+ t cell-glial interactions in mediating alzheimer's disease pathogenesis (supplement)